Lifecore Biomedical, Inc. De (LFCR) Operating Income (2010 - 2025)

Lifecore Biomedical's Operating Income history runs 16 years deep, the most recent figure standing at $5.3 million for Q2 2025.

• In Q2 2025, Operating Income rose 147.88% year-over-year to $5.3 million; the TTM figure through May 2025 stood at -$17.2 million (down 95.01% YoY), while the FY2025 annual figure was -$17.2 million, down 94.99% from the prior year.
• Operating Income was $5.3 million for Q2 2025 at Lifecore Biomedical, up from -$9.0 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of $5.3 million in Q2 2025 to a low of -$11.6 million in Q3 2024.
• Historically, Operating Income has averaged -$3.7 million across 5 years, with a median of -$3.7 million in 2021.
• The sharpest annual moves came in 2021 and 2022: Operating Income jumped 168.56% in 2021, then tumbled 13302.74% in 2022.
• A 5-year view of Operating Income shows it stood at $3.7 million in 2021, then sank by 245.04% to -$5.4 million in 2022, then soared by 72.29% to -$1.5 million in 2023, then sank by 32.1% to -$2.0 million in 2024, then surged by 371.92% to $5.3 million in 2025.
• The last three Operating Income figures came in at $5.3 million (Q2 2025), -$9.0 million (Q1 2025), and -$2.0 million (Q4 2024), per Business Quant data.